Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
01/2008
01/03/2008WO2004081226A3 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use
01/03/2008US20080005809 sequences from maize, soybean and Arabidopsis thaliana associated with transcription factors; genome mapping, gene identification and analysis, plant breeding, preparation of constructs for use in plant gene expression and transgenic plants
01/03/2008US20080004435 Corticotropin releasing factor 2 receptor agonists
01/03/2008US20080004434 prokaryotic host cells comprising a library of at least 103 different RNA molecules each having a dicistronic coding region; for screening a larger portion of the immunological repertoire for receptors having a preselected activity
01/03/2008US20080004432 HEMCM42 antibodies
01/03/2008US20080004231 Disease-Associated Protein
01/03/2008US20080004229 Methods and Compositions Related to Skcg-1, a Tumor Suppressor
01/03/2008US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof
01/03/2008US20080003695 Enriched Pag-55 Fraction and Methods for Early Detection of Preganancy in Ungulate Animals
01/03/2008US20080003693 Methods and materials for detecting frameshift mutations
01/03/2008US20080003646 Stable, humanized, high affinity antibodies against carcinoembryonic antigen (CEA); complementary determining regions; vectors, host cells; pharmacokinetics
01/03/2008US20080003644 Process for Obtaining Antibodies
01/03/2008US20080003643 Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
01/03/2008US20080003623 Monitoring Agent for Seriousness of Hepatitis
01/03/2008US20080003617 Methods for the identification and the isolation of epitope specific antibodies
01/03/2008US20080003614 Mitochondrial anti-viral signaling protein; activates the NF- kappa B and IRF families of transcription factors to induce interferons in viral infected cells to clear viral infection
01/03/2008US20080003608 Highly Specific Polyclonal Antibodies of Individual Core Histone and Uses Thereof
01/03/2008US20080003263 Anti-Gluten Egg Yolk Antibodies for the Treatment of Celiac Disease
01/03/2008US20080003230 Composition for modulating the expression of cell adhesion molecules
01/03/2008US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine
01/03/2008US20080003228 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen
01/03/2008US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof
01/03/2008US20080003226 Method to Reduce Hepatoxicity of Fas-Mediated Apoptosis-Inducing Agents
01/03/2008US20080003224 Compositions and methods for treating haematological proliferative disorders
01/03/2008US20080003221 Compositions and methods for treating inflammatory lung disease
01/03/2008US20080003218 Anti-IgE antibodies
01/03/2008US20080003217 Ilk inhibitors for the treatment of renal disease
01/03/2008US20080003216 Administering an interleukin-18 binding protein (IL-18BP) for inhibiting melanoma cell liver and lung tissue metastasis; IL-18 (IFN gamma-inducing factor)
01/03/2008US20080003210 Non-human primate receptor tyrosine kinases
01/03/2008US20080003178 PIF tetrapeptides
01/03/2008US20080000405 S-adenosylmethionine Synthetase Expression Elements Identified from Arabidopsis thaliana
01/03/2008CA2655874A1 Antibody molecules which bind human il-17
01/03/2008CA2652957A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
01/02/2008EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof
01/02/2008EP1873244A2 Methods and compositions for inhibiting neoplastic cell growth
01/02/2008EP1873239A1 Gene capable of controlling differentiation/growth of plant, and use of the same
01/02/2008EP1872134A2 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
01/02/2008EP1871882A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function
01/02/2008EP1871876A2 Phytase
01/02/2008EP1871810A2 Conjugated anti-psma antibodies
01/02/2008EP1871809A2 Antibodies with immune effector activity and that internalize in endosialin-positive cells
01/02/2008EP1871808A2 Fc VARIANTS WITH OPTIMIZED PROPERTIES
01/02/2008EP1871807A2 Antibodies against cxcr4 and methods of use thereof
01/02/2008EP1871806A2 ANTI-MAdCAM ANTIBODY COMPOSITIONS
01/02/2008EP1871805A2 Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof
01/02/2008EP1871804A2 Reagents that bind ccx-ckr2
01/02/2008EP1871803A1 Stabilized anti-hepatitis b (hbv) antibody formulations
01/02/2008EP1871800A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists
01/02/2008EP1871786A1 Peptide vaccine for influenza virus
01/02/2008EP1871418A2 Humanized anti-cd70 binding agents and uses thereof
01/02/2008EP1871417A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
01/02/2008EP1871416A2 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same
01/02/2008EP1871414A1 Method for traeting inflammatory bowel disease (ibd) by an anti-cd20 antibody
01/02/2008EP1871405A2 Use of rip in treating staphylococcus aureus infections
01/02/2008EP1871171A2 Method of altering the binding specificity of proteins by oxidation-reduction reactions
01/02/2008EP1585954A4 Mammalian sweet and amino acid heterodimeric taste receptors
01/02/2008EP1578205A4 Biomarkers for intro-amniotic inflammation
01/02/2008EP1502116B1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
01/02/2008EP1499346B1 Treatment of type 1 diabetes before and after expression of predisposition markers
01/02/2008EP1317476B1 Reagents for cell selection and methods of use
01/02/2008EP1238056B1 SEROLOGICAL DIAGNOSTIC METHOD WITH i RICKETTSIA PULICIS /i BACTERIUM
01/02/2008EP1098658A4 Engineered proteins for analyte sensing
01/02/2008EP1028978B1 Methods of preparing glycosylated antibodies and antibody fragments having reactive ketone groups
01/02/2008EP0942934B1 Receptor tyrosine kinase genes
01/02/2008EP0610335B1 Methods for designing recombitope peptides
01/02/2008CN101098958A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
01/02/2008CN101098892A Antibodies against IL-13 receptor alpha 1 and uses thereof
01/02/2008CN101098891A Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
01/02/2008CN101098890A Fc variants with altered binding to fcrn
01/02/2008CN101098889A Antibody induced cell membrane wounding
01/02/2008CN101096657A Preparation method of monoclonal antibody against Asial type foot-and-mouth disease virus and usage
01/02/2008CN101096656A Helicobacter pylori recombinant VacA monoclonal antibody and uses thereof
01/02/2008CN101096382A Aglyco products and methods of use
01/02/2008CN101095952A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
01/02/2008CN100359327C Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
01/02/2008CN100359005C Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide
01/02/2008CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses
01/02/2008CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers
01/01/2008US7314920 Antibodies against the PRO4340 polypeptide
01/01/2008US7314919 Human recombinant antibody against the hepatitis C (HCV) non structural NS3 protein nucleic acid and uses thereof
01/01/2008US7314918 PRO6246 antibodies
01/01/2008US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
01/01/2008US7314913 PRO1891 polypeptides
01/01/2008US7314912 AAv scleroprotein, production and use thereof
01/01/2008US7314910 In situ diagnosis, detection of antibodies, immunogenic formulations
01/01/2008US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter
01/01/2008US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor
01/01/2008US7314753 Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli
01/01/2008US7314747 SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors
01/01/2008US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility
01/01/2008US7314734 Muteins of placental growth factor type 1, preparation method and application thereof
01/01/2008US7314733 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders
01/01/2008US7314722 Cytostatin II antibodies and methods
01/01/2008US7314721 Autologous antibody screening; indication of regression, progression or onset
01/01/2008US7314629 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection
01/01/2008US7314622 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
01/01/2008US7314619 Polypeptide for use in the treatment of cancer
01/01/2008US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of
01/01/2008US7314615 IκB Kinase-β (IKKβ) binding antibodies and methods of using same
12/2007
12/27/2007WO2007150077A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer